Corteva, Inc. (NYSE:CTVA) is Aristotle Capital Management LLC's 7th Largest Position

Aristotle Capital Management LLC lessened its stake in Corteva, Inc. (NYSE:CTVA - Free Report) by 1.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 23,371,778 shares of the company's stock after selling 359,018 shares during the period. Corteva accounts for about 2.6% of Aristotle Capital Management LLC's portfolio, making the stock its 7th largest position. Aristotle Capital Management LLC owned 3.40% of Corteva worth $1,331,256,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Flagship Wealth Advisors LLC purchased a new position in shares of Corteva in the 4th quarter valued at $25,000. Noble Wealth Management PBC purchased a new position in Corteva in the fourth quarter valued at about $26,000. Hager Investment Management Services LLC bought a new position in Corteva in the fourth quarter worth about $27,000. LGT Financial Advisors LLC bought a new stake in shares of Corteva in the 4th quarter valued at about $31,000. Finally, Golden State Wealth Management LLC bought a new position in shares of Corteva during the 4th quarter worth approximately $32,000. Institutional investors own 81.54% of the company's stock.

Corteva Price Performance

Shares of CTVA stock traded up $0.10 during trading hours on Tuesday, hitting $62.51. 2,680,710 shares of the company's stock were exchanged, compared to its average volume of 3,310,450. Corteva, Inc. has a fifty-two week low of $50.01 and a fifty-two week high of $66.24. The firm has a market cap of $42.70 billion, a P/E ratio of 48.46, a P/E/G ratio of 1.68 and a beta of 0.72. The company has a quick ratio of 0.93, a current ratio of 1.45 and a debt-to-equity ratio of 0.08. The firm has a 50 day moving average of $60.59 and a two-hundred day moving average of $60.60.

Corteva (NYSE:CTVA - Get Free Report) last announced its earnings results on Wednesday, February 5th. The company reported $0.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a net margin of 5.36% and a return on equity of 7.19%. Sell-side analysts forecast that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 16th. Shareholders of record on Friday, May 2nd will be paid a dividend of $0.17 per share. The ex-dividend date is Monday, June 2nd. This represents a $0.68 annualized dividend and a yield of 1.09%. Corteva's dividend payout ratio (DPR) is presently 52.71%.

Insider Transactions at Corteva

In other news, insider Brian Titus sold 26,560 shares of Corteva stock in a transaction on Thursday, February 20th. The stock was sold at an average price of $63.74, for a total transaction of $1,692,934.40. Following the transaction, the insider now owns 11,347 shares in the company, valued at $723,257.78. The trade was a 70.07 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.14% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have issued reports on CTVA. BNP Paribas raised shares of Corteva to a "hold" rating in a report on Monday, February 10th. The Goldman Sachs Group began coverage on Corteva in a research report on Thursday, March 13th. They set a "buy" rating and a $71.00 target price on the stock. Bank of America boosted their price target on Corteva from $69.00 to $73.00 and gave the stock a "buy" rating in a research note on Tuesday, February 11th. Wells Fargo & Company increased their price objective on shares of Corteva from $67.00 to $73.00 and gave the company an "overweight" rating in a research report on Tuesday, January 28th. Finally, Argus upgraded shares of Corteva from a "hold" rating to a "buy" rating and set a $69.00 price target on the stock in a research note on Monday, March 31st. One research analyst has rated the stock with a sell rating, three have issued a hold rating and twelve have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $68.43.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.